Clinical heterogeneity and diagnostic challenges in CASK-related neurodevelopmental disorders: a longitudinal observational study

• by Iliyana Hristova Pacheva, Elena Timova, Tihomir Todorov, Iglika Sotkova, Katerina Gaberova, Ralitza Yordanova, Tzvetelina Tzvetanova, Fani Galabova, Nevyana Ivanova, Albena Todorova

• July 13, 2026

Fulminant cerebral fat embolism syndrome initially sparing the lungs after long-bone fractures: a case report of refractory status epilepticus

• by Jian Lan, Xingdong Li, Xuesheng Jian, Qiang Zhong, Xijiang Zhang, Cheng Zheng

• July 1, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Elevated serum plasminogen activator inhibitor-1 is associated with seizure burden, drug resistance, and neuroinflammatory markers in pediatric epilepsy

• by Xiao Xiao, Xiaoyan Shi, Jun Feng, Xinyu Zhou, Manli Wang, Bingbing Zhang, Chen Xu, Jihong Tang

• July 14, 2026